Aleš Grošelj

Aleš Grošelj

Auto-generated profile, based on publicly available information

Aleš Grošelj

Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GGGašper Grubelnik
Gašper Grubelnik
EBEmanuela Bostjancic
Emanuela Bostjancic
AGAleš Grošelj
Aleš Grošelj
Nina ZidarNina Zidar
Nina Zidar
Background. Results of previous studies suggest that NANOG may be an important prognostic biomarker in oral squamous cell carcinoma (OSCC), but there are contradictory results regarding NANOG expression patterns on mRNA and protein levels, and the mechanisms of its regulation are poorly understood. Our aim was to analyze the expression and diagnostic significance of NANOG in OSCC, and the possible mechanisms of its regulation, i.e., protein regulators on mRNA level (OCT4, SOX2, KLF4, AGR2, and NOTCH1), methylation status, copy number variation, and regulatory miRNAs, miR-145, miR-335, miR-150, miR-34a, miR-128, and miR-27a. Methods. Our study included 120 patients with OSCC. Expression of NANOG protein and mRNA was analyzed using immunohistochemistry and qPCR. Expression of regulatory factors, miRNAs, and copy number variation was performed using qPCR. Methylation status of NANOG promoter was determined using PCR and Sanger sequencing. Results. We detected upregulation of NANOG and OCT4 and downregulation of NOTCH1 and AGR2 mRNA in OSCC with lymph node metastases compared to OSCC without lymph node metastases. We observed a strong positive correlation between mRNAs of NANOG and those of its protein regulators OCT4, SOX2, NOTCH1, AGR2, and KLF4. The expression of NANOG was in positive correlation with the expression of miR-34a. There was also a correlation between T status of OSCC and the expression of miR-335 and miR-150 and a correlation of miR-150 with the N status of T2 OSCC. NANOG promoter methylation and copy number variation were only observed in a small proportion of samples. Conclusions. Our findings confirm the diagnostic significance of NANOG in OSCC and provide information on NANOG expression patterns on both mRNA and protein levels. They also suggest that protein regulators and microRNAs might play a crucial role, whereas methylation of its promoter and copy number variation probably have a minor role in the regulation of NANOG expression in OSCC.

11 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
DHDoruntina Hoxha
Doruntina Hoxha
AKAljoša Krt
Aljoša Krt
JSJošt Stergar
Jošt Stergar
TTTadej Tomanič
Tadej Tomanič
AGAleš Grošelj
Aleš Grošelj
Matija MilanicMatija Milanic
Matija Milanic
Background: Skin lesions associated with head and neck carcinomas present a diagnostic challenge. Conventional imaging methods, such as dermoscopy and RGB imaging, often face limitations in providing detailed information about skin lesions and accurately differentiating tumor tissue from healthy skin. Methods: This study developed a novel approach utilizing tissue index images derived from hyperspectral imaging (HSI) in combination with machine learning (ML) classifiers to enhance lesion classification. The primary aim was to identify essential features for categorizing tumor, peritumor, and healthy skin regions using both RGB and hyperspectral data. Detailed skin lesion images of 16 patients, comprising 24 lesions, were acquired using HSI. The first- and second-order statistics radiomic features were extracted from both the tissue index images and RGB images, with the minimum redundancy–maximum relevance (mRMR) algorithm used to select the most relevant ones that played an important role in improving classification accuracy and offering insights into the complexities of skin lesion morphology. We assessed the classification accuracy across three scenarios: using only RGB images (Scenario I), only tissue index images (Scenario II), and their combination (Scenario III). Results: The results indicated an accuracy of 87.73% for RGB images alone, which improved to 91.75% for tissue index images. The area under the curve (AUC) for lesion classifications reached 0.85 with RGB images and over 0.94 with tissue index images. Conclusions: These findings underscore the potential of utilizing HSI-derived tissue index images as a method for the non-invasive characterization of tissues and tumor analysis.

14 April 2023 in Cancer Research
Verified
Journal Article
Closed access
Gregor SersaGregor Sersa
Gregor Sersa
MCMaja Cemazar
Maja Cemazar
CJCrt Jamsek
Crt Jamsek
Primož StrojanPrimož Strojan
Primož Strojan
TJTanja Jesenko
Tanja Jesenko
AGAles Groselj
Ales Groselj
Immunotherapies with monoclonal antibodies (checkpoint inhibitors) are currently being intensively researched and have led to excellent response in many cases in various tumors. Another potential approach to immunotherapy is the targeted intratumoral administration of interleukin 12 (IL -12), a cytokine with proven anti-tumor activity. Due to its immunomodulatory effect, it can be used as an immunostimulatory component for in situ vaccination of local ablative therapies. We have developed a phIL12 plasmid without antibiotic resistance markers using a transgene for the human IL -12 p70 protein. The plasmid can be introduced intratumorally by gene electrotransfer. In gene electrotransfer, electrical pulses are applied to the tumor to deliver the plasmid DNA into the cells. Based on nonclinical studies of safety, pharmacokinetics, pharmacodynamics, tolerability, and immunogenicity, a phase I clinical trial of phIL12 gene electrotransfer was conducted (ISRCTN15479959, ClinicalTrials NCT05077033). The primary objective of the study is to evaluate the safety and tolerability of phIL12 gene electrotransfer in the treatment of basal cell carcinoma in patients with operable tumors of the head and neck. The study, an exploratory, dose-escalating Phase I study, will enroll 9 patients in three dose-escalating cohorts. Treatment consists of plasmid injection followed by application of electrical pulses to the tumors. Patients are monitored for 30 days, with tumors removed if a complete response is not achieved. To date, two cohorts of patients have completed the study. No adverse effects or treatment-related toxicities have been observed, and treatment has been well tolerated by patients. The results of this study will provide the basis for the use of phIL12 gene electrotransfer as adjuvant therapy to local ablative therapies to enhance their local effect and elicit a systemic response. Citation Format: Gregor Sersa, Maja Cemazar, Crt Jamsek, Primoz Strojan, Tanja Jesenko, Masa Bosnjak, Ales Groselj. Treatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: A phase I clinical trial [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 2 (Clinical Trials and Late-Breaking Research); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(8_Suppl):Abstract nr CT115.

1 September 2022
Verified
Conference Paper
Open access
JBJan Bogataj
Jan Bogataj
ITIvana Tancer
Ivana Tancer
AGAles Grošelj
Ales Grošelj
Squamous cutaneous skin cancer is common cancer with increasing incidence. Commonly is treated with surgery or radiotherapy, but a new technique has been emerging in recent years. Electrochemo-therapy (ECT) is innovative and still developing treatment of malignant tumors, especially effective in treating cutaneous malignancy. Its feasibility and efficacy have been proven in elderly patients with comorbidities who cannot undergo standard treatments. Some recent studies have focused on reducing bleomycin dose in elderly patients to minimalize side effects and concurrently obtain the same treatment outcome. This article presents a case study of an elder patient with advanced skin cancer, treated with electrochemotherapy with a reduced bleomycin dose, where a complete re-sponse was observed in a long-term follow-up period. Keywords: Electrochemotherapy; Bleomycin; Reduced dose; Squamous cell carcinoma; Elderly pa-tient